Aristo Bio Tech Lifescience Ltd vs Nacl Industries Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Jun 11, 2026

Key Highlights

The Latest Trading Price of Aristo Bio-Tech & Lifescience Ltd is ₹ 91.05 as of 11 Jun 15:30 . The P/E Ratio of Aristo Bio-Tech & Lifescience Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of NACL Industries Ltd changed from 14.6 on March 2021 to 0 on March 2025 . This represents a CAGR of -100.00% over 5 years The Market Cap of Aristo Bio-Tech & Lifescience Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of NACL Industries Ltd changed from ₹ 745.63 crore on March 2021 to ₹ 2047 crore on March 2025 . This represents a CAGR of 22.39% over 5 years The revenue of Aristo Bio-Tech & Lifescience Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of NACL Industries Ltd for the Mar '26 is ₹ 362.56 crore as compare to the Dec '25 revenue of ₹ 318.28 crore. This represent the growth of 13.91% The ebitda of Aristo Bio-Tech & Lifescience Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of NACL Industries Ltd for the Mar '26 is ₹ 14.88 crore as compare to the Dec '25 ebitda of ₹ 6.75 crore. This represent the growth of 120.44% The net profit of Aristo Bio-Tech & Lifescience Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% The net profit of NACL Industries Ltd changed from ₹ -20.8 crore to ₹ -0.86 crore over 8 quarters. This represents a CAGR of -79.67% The Dividend Payout of Aristo Bio-Tech & Lifescience Ltd changed from 4.78 % on March 2023 to 8.39 % on March 2025 . This represents a CAGR of 20.63% over 3 yearsThe Dividend Payout of NACL Industries Ltd changed from 15.61 % on March 2021 to 0 % on March 2025 . This represents a CAGR of -100.00% over 5 years .

About Aristo Bio-Tech & Lifescience Ltd

Aristo Bio-Tech & Lifescience Limited was originally incorporated on March 17, 2005 as 'Aristo Bio-Tech and Lifescience Private Limited' with the Registrar of Companies, Maharashtra, Mumbai.
Subsequently Company converted into Public Limited Company and name of company was changed to 'Aristo Bio-Tech and Lifescience Limited' vide fresh Certificate of Incorporation dated May 20, 2020.
The Company came out with a Public Issue by allotting 18,12,800 Equity Shares of face value of Rs 10 each in January, 2023 by raising funds of Rs. 13.05 Cr. through Fresh Issue. Aristo Bio-Tech & Lifescience is an agrochemical company engaged in the manufacturing, formulation, supplying, packaging and job work services in various Pesticides such as Insecticides, Herbicides, Fungicides, Plant Growth Regulators and other Agrochemicals.

About NACL Industries Ltd

NACL Industries Limited (Earlier known as Nagarjuna Agrichem Limited) was incorporated in November, 1986 to engage in hire purchase, leasing and deposit mobilisation.
The Company changed its name from Nagarjuna Agrichem Limited to NACL Industries Limited on September 4, 2017.
The Company is in the business of crop protection and manufactures both Technicals (Active Ingredient) and Formulations.
It manufactures pesticides, insecticides, acaricides, herbicides, fungicides and other plant growth chemicals.
NACL Industries has now become part of the Murugappa Group, Rs 778 billion conglomerate. In Oct.'94, it came out with a public issue of 23.70 lac shares at a premium of Rs 5, aggregating Rs 3.56 cr, to part-finance a Rs 24-cr project to manufacture monocrotophos (MCP) technicals and MCP formulations.

FAQs for the comparison of Aristo Bio-Tech & Lifescience Ltd and NACL Industries Ltd

Which company has a larger market capitalization, Aristo Bio-Tech & Lifescience Ltd or NACL Industries Ltd?

Market cap of Aristo Bio-Tech & Lifescience Ltd is 61 Cr while Market cap of NACL Industries Ltd is 3,863 Cr

What are the key factors driving the stock performance of Aristo Bio-Tech & Lifescience Ltd and NACL Industries Ltd?

The stock performance of Aristo Bio-Tech & Lifescience Ltd and NACL Industries Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Aristo Bio-Tech & Lifescience Ltd and NACL Industries Ltd?

As of June 11, 2026, the Aristo Bio-Tech & Lifescience Ltd stock price is INR ₹91.0. On the other hand, NACL Industries Ltd stock price is INR ₹164.95.

How do dividend payouts of Aristo Bio-Tech & Lifescience Ltd and NACL Industries Ltd compare?

To compare the dividend payouts of Aristo Bio-Tech & Lifescience Ltd and NACL Industries Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.